Impaired NK Cytolytic Activity and Enhanced Tumor Growth in NK Lytic-Associated Molecule-Deficient Mice
N atural killer cells are lymphocytes of the innate immune system that play an important role in early host defense against tumors and infectious agents (1) . NK cells can induce target cell death by a variety of mechanisms. However, the primary mechanism of killing is the release of cytotoxic granules containing perforin and granzymes (2) (3) (4) . It has long been known that NK-mediated killing can be augmented by cytokines, including IL-2, IL-12, IL-15, and IFN (5) (6) (7) (8) . In studies to characterize additional proteins associated with the cytolytic process, we identified a novel protein whose expression was highly increased upon cytokine stimulation of NK cells (9) . This protein was named NK lytic-associated molecule (NKLAM). 4 NKLAM is found in the cytolytic granule membranes of NK cells and CTL. It is weakly expressed in resting NK cells and unlike perforin and granzymes, there is little to no preformed NKLAM mRNA or protein in NK cells. Upon target cell stimulation or after incubation with cytokines that enhance NK killing, NKLAM mRNA levels in NK cells increase and protein is synthesized and becomes targeted to cytoplasmic granule membranes. Studies have shown a role for NKLAM in perforin/granzyme-mediated cytolysis. Treatment of NK cells or CTL with NKLAM antisense oligonucleotides inhibits their killing activity, indicating that NKLAM participates in the cytotoxic process (9, 10) .
To establish what function NKLAM plays in NK-mediated killing, we focused our attention on the physical characteristics of NKLAM protein. NKLAM contains three cysteine-rich domains that form a really interesting new gene (RING)-in between RING (IBR)-RING domain structure. This tripartite domain is also collectively known as a TRIAD or RBR (11, 12) . There are currently over 140 RING-IBR-RING containing proteins in a wide variety of organisms, from yeast to human (13) . Many of these proteins are associated with diverse protein-protein interactions. A subset of these proteins has been found to possess E3 ubiquitin ligase activity (12, 13) . E3 ubiquitin ligases regulate the ubiquitination of proteins, catalyzing the transfer of activated ubiquitin from an E2 ubiquitin-conjugating enzyme to its substrate (14, 15) . Multiple E3 ubiquitin ligases have been shown to have important roles in a variety of immune functions (16) . For example, GRAIL is associated with the induction of anergy in CD4 ϩ T cells (17) . Triad3A targets TLRs for ubiquitination and subsequent degradation (18) . We have identified NKLAM as an E3 ubiquitin ligase but have not yet determined how this enzymatic activity results in enhanced NK cytolytic function (19) .
To further investigate the role of NKLAM in cell-mediated cytotoxicity, NKLAM-deficient mice were generated. These mice appear normal and are fertile. They have normal numbers of NK cells in the spleen. NK cells from NKLAM knockout (KO) mice have comparable amounts of perforin, granzyme B, and lysosomal membrane-associated protein 1 (LAMP-1; CD107a) in their cytoplasmic granules as NK cells from wild-type (WT) mice. However, these NKLAM-deficient NK cells display significantly less NK activity in vitro than WT cells and produce less IFN-␥ upon target cell stimulation. In addition, NKLAM-deficient mice exhibit enhanced numbers of pulmonary metastases after injection with B16 melanoma cells. These studies indicate a significant role for NKLAM in NK cytotoxic function in vitro and in vivo.
Materials and Methods

Constructs
NKLAM genomic clones were isolated from a 129 SvJ mouse liver genomic library ( Fix II; Stratagene) by hybridization using mouse NKLAM cDNA clones as previously described (10) . Five overlapping phage clones were obtained and the exon/intron boundaries were characterized by PCR and sequencing. The targeting construct was generated using the pKO scrambler NTKV-1905 vector (Stratagene). This vector contains a neomycin resistance (neo) cassette for positive selection and a HSV thymidine kinase (TK) cassette outside the region of homology to allow for negative selection. The 5Ј arm of the targeting construct was a 3.5-kb EcoRI/KpnI fragment located within intron 1 of NKLAM. The 3Ј arm was a 6-kb EcoRI/EcoRI fragment extending from intron 5 to intron 8. This produced a targeting vector of 15 kb, which upon homologous recombination would replace exons 2-5 of NKLAM with the neo cassette. This construct was linearized with NotI and electroporated into 129Sv/Ev embryonic stem cells (inGenious Targeting Lab). The neo-expressing embryonic stem cells were selected in medium containing G418; DNA from G418-resistant clones was isolated and evaluated for homologous recombination by a combination of Southern blotting and PCR. PCR with forward primer SMINTR1D (inside intron 1 within the 5Ј arm) and reverse primer A1570 (inside exon 6 within the 3Ј arm) generated a WT product of 7.4 kb and a KO product of 3 kb (PCR 1). Primers were SMINTR1D: GCTATTGTTTCAAGCTGTGAG and AM1570: CACCTC CACGGCAAAGAGAAATGG. Clones showing the 3-kb KO band were confirmed as recombinant by two additional PCR using neo primers combined with NKLAM-specific primers on either side of the targeting arms (data not shown).
Production of NKLAM-deficient mice
Two recombinant embryonic stem cell clones were microinjected into C57BL/6 blastocysts by inGenious. Coat color chimeric males (90 -100% agouti) were then mated with C57BL/6 female mice and the progeny were screened for germline transmission of the KO allele. Crossing of heterozygous mice produced viable homozygous KO offspring. Pups were genotyped using DNA extracted from tail tissue by PCR 1. Heterozygous mice have subsequently been backcrossed for 11 generations onto a C57BL/6 background. C57BL/6 mice were obtained from the National Cancer Institute. Early in the backcross process, progeny were selected for the C57BL/6 NK gene complex alleles by PCR so that the NK cells from these mice were genotypically C57BL/6 (20) . Primers for NKRP1a were: forward, TGCTTGACTCAAATTCATGAGG; reverse, ATTTTACTCGA CACCAGGTTGA, B6 allele 110 nt, 129 allele 133 nt. Primers for Ly49a were: forward, GCCTCTGAGGTTCATGTTTGATT; reverse, TTCCTTC CCTGTTGAGACTG, B6 allele 340 nt, 129 allele 321 nt. We observed no significant differences in the results obtained from non-backcrossed and fully backcrossed NKLAM homozygous KO mice. All mice were maintained in specific pathogen-free barrier housing and all experiments were conducted in accordance with institutional animal care and use guidelines.
Cell lines
YAC-1 and B16-F10 melanoma cells were purchased from the American Type Culture Collection. The NK-sensitive mouse lymphoma YAC-1 cell line was maintained in medium containing RPMI 1640 supplemented with 7.5% FBS and 1% glutamine. They were split twice a week and maintained at a density of 2 ϫ 10 5 cells/ml. B16 melanoma cells were propagated in DMEM containing 7.5% FBS and 1% glutamine. Subconfluent adherent cells were trypsinized and split twice a week.
Isolation of spleen cells
Spleens were harvested, rinsed in RPMI 1640, and gently homogenized using the blunt end of a 3-ml syringe. Released spleen cells were pelleted and then layered over a Lympholyte-M density gradient (Cedarlane Laboratories/ Accurate Chemical Corporation) according to the manufacturers' instructions to remove RBC, dead cells, and debris. Lymphocytes at the interface were collected, washed twice with RPMI 1640, and counted. These cells were analyzed by flow cytometry and/or used for the purification of NK cells.
Flow cytometry
Flow cytometry was performed to analyze spleen cell subpopulations and NK cells from WT and NKLAM-deficient mice. Briefly, tubes containing 2 ϫ 10 5 -2 ϫ 10 6 cells in 0.05 ml of flow buffer (ice-cold PBS plus 1% FBS plus 0.1% sodium azide) were incubated with 1 l of Fc block (BD Pharmingen) for 10 min at 4 o C. Fluorescent-conjugated cell surface-specific primary Abs were then added and incubated for an additional 30 min at 4 o C. Cells were washed twice with flow buffer and then either fixed with 0.2 ml of PBS plus 1% formaldehyde or prepared for intracellular staining using the BD Cytofix/Cytoperm Plus Fixation/Permeabilization Kit with GolgiStop according to the manufacturer's directions. Cells were analyzed on a BD Biosciences FACSCalibur flow cytometer. Abs purchased from BD Biosciences were FITC-CD3 (no. 553061), Alexa Fluor 700-CD3 (no. 557984), allophycocyanin-NK1.1 (no. 550627), PE-Cy7-NK1.1 (no. 552878), PE-streptavidin (no. 13025D), PE-CD27 (no. 558754), PerCP-CD45 (no. 557235), PE-CD49b (DX5; no. 553858), allophycocyanin-CD62L (L-selectin; no. 553152), PE-CD8a (no. 553032), allophycocyanin-CD4 (no. 553051), allophycocyanin-CD19 (no. 550992), FITC-Gr-1 (Ly-6G and Ly-6C; no. 553126), PE-CD11b (no. 557397), PE-Cy7-CD11b (no. 553311), PE-CD25 (no. 553866), biotin-KLRG1 (no. 5500863), PE-NKG2D (no. 558403), FITC-Ly49C/I (no. 553278), PE-Ly49A (no. 557424), and control Abs were FITC-IgG1 (no. 553971), PE-IgG2b (no. 553987), and allophycocyanin-IgG2a (no. 553932). Abs purchased from eBioscience were FITC-NKp46 (no. 11-3351-80), PE-Ly49I (no. 12-5895), PE-granzyme B (no. 12-8899-41), and FITC-perforin (no. 11-9392-82). Ly49H, Ly49A, and Ly49I Abs were generously provided by Dr. M. Buller (St. Louis University). Samples were analyzed using FlowJo software (Tree Star).
Purification of NK cells and stimulation
NK cells were isolated from spleen cells using magnetic CD49b (DX5) microbeads, a MiniMACS Separator, and MS columns according to the manufacturer's recommendations (Miltenyi Biotec) (21) . These cells were routinely Ͼ92% DX5 by FACS analysis. For cytokine stimulation, NK cells were cultured at 5 ϫ 10 6 cells/ml in RPMI 1640 containing 10% FBS, 1% glutamine, 5 ϫ 10 Ϫ5 M 2-ME, and 500 U/ml rIL-2. IL-2 was a gift from Chiron. For some experiments, unseparated spleen cells were similarly cultured in IL-2 in parallel.
NK cells were activated in vivo by i.p. injection of mice with 200 g of polyinosinic:polycytidylic acid (poly(I:C), sodium salt; Sigma-Aldrich). Control mice were injected with PBS. After 24 h, spleen cells or purified NK cells were assayed for NK activity in vitro.
Killing assays and granule exocytosis
Unstimulated and IL-2-stimulated purified NK cells were used as effectors in cytotoxicity assays against the 51 Cr-labeled NK-sensitive mouse lymphoma cell line YAC-1, as previously described (10) . Assay conditions were set up in triplicate wells at various E:T ratios in 96-well round-bottom microtiter plates. After incubation for 4 h at 37 o C, supernatants (0.1 ml) were harvested and the amount of 51 Cr release from YAC-1 target cells was detected using a Packard Cobra II gamma counter. The percent specific lysis of targets was calculated as previously described. The SD of triplicate values never exceeded 10% in all experiments.
Granule exocytosis was monitored by the release of ␤-glucuronidase using the fluorogenic substrate 4-methylumbelliferyl-␤-D-glucuronide (22) . Reagents used in this assay were purchased from Sigma-Aldrich. Four ϫ 10 5 spleen cells or 2.5 ϫ 10 5 purified NK cells were incubated with 0.025 ml of RPMI 1640 containing 4% FBS in 96-well plates. PMA (40 ng/ml) plus calcium ionophore A23187 (2 g/ml) was used to induce granule exocytosis. Total release was obtained by incubation of cells with 1% Triton X-100. After 4 h at 37 o C, cells were pelleted and supernatants were harvested. In brief, 0.005 ml of supernatant was added to triplicate wells of 96-well black microtiter plates and mixed with 0.05 ml of ␤-glucuronidase substrate (1.5 mM 4-methylumbelliferyl-␤-D-glucuronide in 0.05 M sodium acetate, 0.01% BSA, and 0.1% Triton X-100, pH 4). Plates were incubated for 10 min at 37 o C. The reaction was stopped by the addition of 0.175 ml of 0.25 M sodium tetraborate. The fluorescence intensity was measured with excitation at 355 nm and emission of 460 nm in a Wallac Victor 1420 multilabel counter.
IFN-␥ production
Unstimulated and IL-2-stimulated purified NK cells were cocultured with YAC-1 target cells in triplicate wells at E:T ratios of 25:1 and 10:1, respectively, in 96-well round-bottom microtiter plates. After incubation for 4 h at 37 o C, supernatants (0.1 ml) were harvested and the amount of IFN-␥ was quantitated by ELISA (Endogen and Pierce Biotechnology) according to the manufacturers' protocol.
Immunoblot analysis
Rat monoclonal anti-LAMP-1 (CD107a) mAb 1D4B, provided by Dr. J. T. August, was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the National Institute of Child Health and Human Development and maintained by the University of Iowa (Department of Biological Sciences, Iowa City, IA) (23) . It was used at 1/100. Anti-perforin Ab (no. 3693, 1/1,000) and anti-granzyme B Ab (no. 4275, 1/1000) were purchased from Cell Signaling. Anti-␤-actin mAb clone AC-15 (1/10,000) was purchased from Sigma-Aldrich. NKLAM mAb 35 was produced in our laboratory and used at 35 g. Immunoblots were performed as previously described (19) . Briefly, cell extracts were prepared from purified NK cells from NKLAM-deficient and WT mice by lysing cells in buffer containing 20 M PIPES, 4% sucrose, 100 mM NaCl, and 0.5% Nonidet P-40 plus protease inhibitors (25 g/ml aprotinin, leupeptin, pepstatin, 2 mM benzamidine, 1 mM PMSF). Lysates were sonicated twice for 10 s each, then mixed with 2ϫ SDS loading buffer. Samples were boiled for 20 min and loaded onto 7.5% SDS-PAGE at 100 -150 V. Proteins were transferred to polyvinylidene difluoride membranes, incubated with blocking buffer for various times (10 mM Tris, 150 mM NaCl, 0.2% Tween 20, and 5% blotto) and then incubated with primary Ab. Secondary Abs were HRP-conjugated goat anti-mouse IgG (1/10,000; Bio-Rad), goat anti-rabbit (1/2,000; Cell Signaling), or donkey anti-rat IgG (1/5,000; Millipore). Membranes were then placed in Supersignal Chemiluminescence solution (Pierce) and exposed to film.
Lung metastasis studies
B16 melanoma cells were injected i.v. through the tail vein into NKLAMdeficient KO and WT mice. Cells were washed with PBS and each mouse was injected with 300,000 cells in 0.2 ml of PBS. Fifteen days later, animals were sacrificed and lungs were harvested and fixed in Fekete's solution. Individual lobes were dissected and black B16 melanoma metastatic nodules were enumerated on each lobe surface in a blinded fashion. Data were analyzed using a two-tailed Student's t test.
Results
Generation of NKLAM-deficient mice
Genomic clones containing mouse NKLAM were isolated from a 129SvJ library. The NKLAM gene contains nine exons, spanning over 29 kb. It was not possible to knock out exon 1, containing the start codon, because intron 1 is extremely large, over 14 kb. Therefore, a targeting vector was constructed in which exons 2-5 (ϳ6 kb) were replaced with a neo cassette (Fig. 1A) . This removed the second and third cysteine-rich domains of NKLAM, which together form a RING-IBR-RING structure, important in the E3 ubiquitin ligase activity of NKLAM. It also removed two of the three predicted transmembrane domains. This construct was transfected into 129Sv/Ev embryonic stem cells. The neo clones were selected in medium containing G418; homologous recombinant clones were identified by a combination of Southern blotting and PCR. Two recombinant clones were subsequently microinjected into C57BL/6 blastocysts. Chimeric heterozygotes that displayed germline transmission were intercrossed to produce NKLAM Ϫ/Ϫ progeny (Fig. 1B) . Heterozygotes were simultaneously backcrossed to C57BL/6 mice for 11 generations to generate NKLAMdeficient mice on a C57BL/6 background. Early in the backcross process, heterozygous progeny were selected for the C57BL/6 NK gene complex alleles by PCR so that the NK cells from these mice were genotypically C57BL/6. Progeny were evaluated by a combination of both Southern blotting and PCR. RT-PCR confirmed the absence of NKLAM mRNA in IL-2-stimulated spleen cells from NKLAM Ϫ/Ϫ mice compared with heterozygous (ϩ/Ϫ) and WT (ϩ/ϩ) mice (Fig. 1B) .
Homozygous NKLAM-deficient (Ϫ/Ϫ) mice were born at the expected Mendelian ratio. Overall, the mice appeared normal and were fertile. Histological examination of the major organs of 8-wkold NKLAM Ϫ/Ϫ and heterozygous (ϩ/Ϫ) mice revealed no overt abnormalities by light microscopy. NKLAM Ϫ/Ϫ mice were observed for over 18 mo. They developed normally and there was no obvious difference in gross morphology, size, or body weight between WT and NKLAM-deficient mice during the 18-mo period (data not shown).
Normal distribution of lymphoid cells in the spleens of NKLAM-deficient mice
The distribution of lymphoid cells in the spleens of NKLAM Ϫ/Ϫ and NKLAM ϩ/ϩ mice was analyzed by flow cytometry. There was no significant difference in the absolute numbers of lymphoid cells in NKLAM-deficient and WT mice; the total number of spleen cells was 87.5 Ϯ 9.2 ϫ 10 6 in NKLAM-deficient mice and Ϫ DX5 ϩ NK cells were evaluated. We also looked at the proportion of DX5 ϩ NK cells coexpressing CD62L (L-selectin). In humans, L-selectin expression is associated with an immature NK cell phenotype (24) . In mice, L-selectin expression on NK cells may influence the migration of NK cells to various lymphoid organs (25) . As shown in Table I , there were no differences in any of the cell populations between NKLAM-deficient and WT mice.
Analysis of the number of CD3 Ϫ NK1.1 ϩ NK cells and the NK receptor repertoire was also performed. NKLAM-deficient and WT mice had equivalent levels of CD3 Ϫ NK1.1 ϩ cells (Table I) . Examination of gated CD3 Ϫ NK1.1 ϩ splenic NK cells for NK inhibitory and activating receptors showed no differences in the expression of NKp46, NKG2D, NKG2DA/C/E, Ly49A, Ly49C/I, Ly49D, Ly49H, Ly49I, and KLRG1 between KO and WT NK cells (Table I and Fig. 2) . Therefore, the lack of NKLAM expression does not significantly alter the numbers or distribution of NK populations or other lymphocyte subsets in the spleen.
Maturation of NK cells was first shown to be accompanied by an up-regulation of CD11b (Mac-1) expression (26) . It was subsequently demonstrated that mouse NK cells could be dissected into four subsets based on cell surface density of CD27 and CD11b (27) (28) (29) Ϫ NK1.1 ϩ NK cells from the spleens of NKLAM-deficient and WT mice was evaluated. As shown in Fig.  2 , NKLAM KO and WT mice have similar levels of these subsets. In addition, as described, the percentage of NK cells expressing Ly49C/I in the CD11b low subsets of both KO and WT mice was much lower (8%) than in the CD11b high subsets (30%) (data not shown). Overall, these results suggest no NK maturational alterations in NKLAM-deficient mice.
NKLAM-deficient mice display lower splenic NK activity in vitro
Previous studies have shown that NKLAM is located in NK cytolytic granule membranes (9) . In addition, treatment of NK cells with NKLAM antisense oligonucleotides reduces both NKLAM levels and NK-mediated cytotoxicity, indicating a role for NKLAM in NK killing. Therefore, NK cells from NKLAM-deficient mice were predicted to have lower NK activity. To test this hypothesis, DX5 ϩ NK cells from the spleens of NKLAM Ϫ/Ϫ , ϩ/Ϫ, and ϩ/ϩ WT mice were isolated by magnetic bead column purification. Total numbers of NK cells were comparable among the three groups. Freshly isolated NK cells were tested for killing of NK-sensitive YAC-1 tumor target cells in 4-h 51 Cr release assays. As shown in Fig. 3 , NK cells from NKLAM Ϫ/Ϫ mice had significantly lower spontaneous NK activity in vitro compared with NKLAM ϩ/Ϫ heterozygous mice or WT mice. This represents a 60% reduction in NK killing of YAC-1 targets by NKLAMdeficient NK cells.
NKLAM expression is greatly increased in NK cells after treatment with cytokines that enhance NK killing, such as IL-2 and IFN. We therefore compared the cytotoxic activity of resting and in vitro IL-2-stimulated NK cells from NKLAM Ϫ/Ϫ and WT mice. As seen previously, resting NK cells from NKLAM-deficient mice had lower NK activity than cells from WT littermates. Interestingly, IL-2 enhanced the killing activity of both NKLAM-deficient and WT NK cells. However, the level of killing by IL-2-stimulated NK cells from NKLAM Ϫ/Ϫ mice was still much less than the killing mediated by IL-2-stimulated WT NK cells (Fig. 4) . Cumulatively, these results indicate that NKLAM plays a role in NK cytotoxicity in vitro. However, it is not absolute in that there is residual killing displayed by NKLAM-deficient NK cells, which can be enhanced by exposure to IL-2. This suggests that NKLAM is one of multiple factors contributing to the total amount of cytotoxicity mediated by DX5 ϩ NK cells.
NKLAM-deficient NK cells display normal granule exocytosis and granule contents
Since NKLAM is found in the membrane of cytolytic granules, it is possible that it plays a role in the migration and/or fusion of granules to the cell membrane during the process of granule exocytosis when NK cells are activated to kill. NKLAM levels are low in resting NK cells and unlike other granule membrane proteins like CD107a (LAMP-1), there is little to no preformed NKLAM in cytolytic granules (9, 30) . Upon target cell stimulation, NKLAM levels increase. To determine whether NKLAM plays a role in granule exocytosis, spleen cells and purified NK cells from NKLAM Ϫ/Ϫ and WT mice were treated with PMA and calcium ionophore A23187 to trigger granule exocytosis. Four hours later, the supernatants were monitored for ␤-glucuronidase, a soluble component of the granules and a measure of granule release. Total levels of ␤-glucuronidase in the cells were determined by detergent (Triton X-100) lysis. As shown in Fig. 5 , the total and released amounts of ␤-glucuronidase in NKLAM-deficient and WT cells were comparable. This indicates that NKLAM is likely not required for granule exocytosis and/or release of soluble granule components.
Granule exocytosis-mediated killing of tumor targets requires functional granules containing perforin and granzymes. If NKLAM alters the expression and/or function of these proteins, it could alter the killing activity of NK cells. Therefore, the levels of perforin, granzyme B and the granule membrane protein CD107a in NKLAM Ϫ/Ϫ and WT NK cells were evaluated. A representative immunoblot is shown in Fig. 6 . The amount of perforin, granzyme B, and CD107a was quantitated by densitometry and normalized to the levels of ␤-actin. We found no significant differences in perforin, granzyme B, or CD107a expression between NKLAM Ϫ/Ϫ and WT NK cells, suggesting that NKLAM does not alter the ϩ population. There were no significant differences in the absolute number or distribution of lymphocyte or NK subsets between WT (ϩ/ϩ) and NKLAM-deficient (Ϫ/Ϫ) mice.
FIGURE 2.
Normal NK cell subsets and receptor repertoire in NKLAM-deficient mice. Representative flow cytometry results from eight independentexpression of these proteins. However, we cannot rule out the possibility that there may be functional differences in the proteins between these mice. NKLAM was undetectable in KO cells.
Intracellular levels of perforin and granzyme B were also analyzed by flow cytometry. Fig. 2A (third panel) depicts the intracellular expression of these proteins in NKLAM KO-and WTpurified NK cells stimulated for 3 days with IL-2. Cells from NKLAM KO and WT mice have comparable levels of granzyme B and perforin; Ͼ97% of the CD3 Ϫ NK1.1 ϩ NK cells express granzyme B and Ͼ70% express perforin. Similar results were seen in three independent experiments. Total splenocytes from NKLAM-deficient and WT mice were also cultured for 3 days in IL-2. Granzyme B and perforin levels in the KO and WT CD3 Ϫ NK1.1 ϩ cells in these cultures were also comparable, with Ͼ97% of the cells expressing granzyme B and ϳ45% expressing perforin (data not shown). The flow cytometry results correlate with the protein levels seen in immunoblot analysis. Consistent with studies by Fehninger et al. (8) , granzyme B and perforin were undetectable in purified, unstimulated NK cells.
NKLAM-deficient mice produce less IFN-␥ upon target stimulation in vitro
In addition to cytotoxic activity against YAC-1 tumor cells, we compared the production of IFN-␥ by NKLAM-deficient and WT NK cells after target cell stimulation. Freshly isolated, purified, unstimulated NK cells or NK cells stimulated with IL-2 for 3 days in vitro were cocultured with YAC-1 target cells at E:T ratios of ϩ NK cells from the spleens of NKLAM KO (Ϫ/Ϫ) and WT (ϩ/ϩ) mice were isolated by magnetic bead column purification. Cells were then cultured at 5 ϫ 10 6 cells/ml in RPMI 1640 containing 10% FBS, 1% glutamine, and 5 ϫ 10 Ϫ5 M 2-ME for 3 days with and without 500 U/ml rIL-2. These cells were assessed for cytolytic activity against 51 Cr-labeled YAC-1 target cells in 4-h killing assays at the E:T ratios shown. Error bars represent the SDs from five independent experiments. 5 purified NK cells from NKLAM KO or WT mice were incubated with 0.025 ml of RPMI 1640 containing 4% FBS in 96-well plates. PMA (40 ng/ml) plus calcium ionophore A23187 (2 g/ml) (P ϩ I) was used to induce granule exocytosis. Total release was obtained by incubation of cells with 1% Triton X-100. After 4 h at 37 o C, 0.005 ml of supernatant was added to triplicate wells of 96-well black microtiter plates and mixed with 0.05 ml of ␤-glucuronidase substrate. Plates were incubated for 10 min at 37 o C. The reaction was stopped by the addition of 0.175 ml of 0.25 M sodium tetraborate. The fluorescence intensity was measured in a Wallac Victor 1420 multilabel counter. Error bars represent the SEM from five independent experiments. unstim, Unstimulated.
FIGURE 6.
Immunoblot analysis of granule proteins in NKLAM-deficient and WT mice. Purified NK cells from the spleens of NKLAM-deficient KO and WT mice were stimulated with IL-2 (500 U/ml) in vitro for 3 days. Cell lysates were then prepared as described and subjected to Western blot analysis. The amount of perforin, granzyme B and CD107a from four independent experiments was quantitated by densitometry and normalized to the levels of ␤-actin. Levels of expression between KO and WT cells varied by Ͻ25% for each protein and were not significantly different. NKLAM protein was undetectable in KO cells.
25:1 and 10:1, respectively. After 4 h of incubation, levels of IFN-␥ in the supernatants were quantitated by ELISA. As shown in Fig. 7 , freshly isolated NK cells from WT mice produced more IFN-␥ than NK cells from NKLAM KO mice after coculture with YAC-1 (93 pg/ml vs 64 pg/ml). The difference in IFN-␥ production between WT and KO NK cells was even more dramatic when cells were first cultured in IL-2 for 3 days before the 4 h YAC-1 costimulation (1399 pg/ml vs 561 pg/ml).
NK activity in NKLAM-deficient mice is stimulated in vivo by poly(I:C)
NK activity is enhanced by in vivo exposure to poly(I:C). Twentyfour hours after i.p injection of mice with poly(I:C) or PBS, spleen cells or purified NK cells from NKLAM-deficient and WT mice were assayed for NK activity in vitro. Poly(I:C) increased the killing activity of splenocytes and purified NK cells from both NKLAM KO and WT mice to the same extent (Fig. 8) .
Enhanced lung metastases in NKLAM-deficient mice
The B16 melanoma model of experimental lung metastasis has been widely used in studies of NK function (31) (32) (33) . In these experiments, NKLAM Ϫ/Ϫ and WT mice were injected i.v. with 300,000 B16 melanoma cells. Fifteen days later, black metastatic melanoma colonies in the lungs were counted. NKLAM-deficient mice had substantially higher numbers of lung metastases compared with WT controls (mean 92 nodules vs 32, p Ͻ 0.01; Fig. 9 ). Since a gender difference in response to B16 melanoma was reported in NK receptor 2B4 Ϫ/Ϫ mice, tumor metastasis in both NKLAM Ϫ/Ϫ and ϩ/ϩ males and females was evaluated (34) . We observed no gender differences; both male and female NKLAM Ϫ/Ϫ mice showed greater numbers of tumors than their WT gender-matched controls (Fig. 9B) . In addition to having more metastases, both male and female NKLAM-deficient mice had larger tumor nodules than WT mice (Fig. 9A) . These results indicate that NKLAM-deficient mice have diminished capacity to control tumor metastases in vivo and support the role for NKLAM in NK function in vivo.
Discussion
This report describes the generation and initial characterization of mice with a targeted genetic deletion of NKLAM. NKLAM is a RING-IBR-RING finger-containing transmembrane protein found in NK cytolytic granules. It is weakly expressed in resting NK cells; upon target cell stimulation or after incubation with cytokines that enhance NK killing, NKLAM mRNA levels in NK cells increase and protein is synthesized and becomes targeted to cytoplasmic granule membranes. Previous studies have shown a role for NKLAM in perforin/granzyme-mediated cytolysis. Treatment of NK cells with NKLAM antisense oligonucleotides inhibits their killing activity, indicating that NKLAM participates in the cytotoxic process.
To further evaluate the role of NKLAM in NK function in vivo, NKLAM-deficient mice were generated. These mice were initially 129Sv/Ev ϫ C57BL/6 and have been backcrossed for 11 generations onto a B6 background. During this process, we observed no significant differences in the results obtained from non-backcrossed and fully backcrossed NKLAM homozygous KO mice. NKLAM-deficient mice were monitored for Ͼ18 mo. Overall, the mice appeared normal and were fertile. Histological examination of the major organs of NKLAM Ϫ/Ϫ and ϩ/Ϫ mice revealed no overt abnormalities by light microscopy. NKLAM Ϫ/Ϫ mice developed normally and there was no obvious difference in gross morphology, size, or body weight between WT and NKLAM-deficient mice during the 18-mo period.
We also observed no differences in the numbers or distribution of lymphoid populations in the spleens of NKLAM Ϫ/Ϫ mice compared with WT animals. The numbers of CD3 ϩ , CD4 ϩ , and CD8
Ϫ DX5 ϩ , and CD3 Ϫ NK1.1 ϩ NK cells in both groups of mice were identical. We also looked at the proportion of DX5 ϩ NK cells coexpressing CD62L (L-selectin). In humans, L-selectin expression is associated with an immature NK cell phenotype (24) . In mice, L-selectin expression on NK cells may influence the migration of NK cells to various lymphoid organs (25) . Again, there was no significant difference in the proportion of DX5 ϩ L-selectin ϩ cells in NKLAM ϩ/ϩ and Ϫ/Ϫ mice. We also saw no maturational differences between NKLAM KO and WT spleen NK cells based on the levels of coexpression of CD27 and CD11b as described previously (26 -29) . Analysis of NK inhibitory and activating receptor expression by splenic NK cells in NKLAM-deficient and WT mice also showed no differences. Evaluation of NK populations in other organs in NKLAM-deficient mice, including bone marrow, lymph node, liver, and lungs, is currently in progress.
Although NKLAM-deficient mice have normal numbers of splenic NK cells and a normal NK receptor repertoire, these cells display significantly less cytotoxic activity against YAC-1 target cells in vitro compared with heterozygous or WT control cells. This demonstrates unequivocally that NKLAM plays a role in NKmediated cytotoxicity. However, it also indicates that NKLAM is not absolutely required for all NK-mediated killing. Similarly, when purified NK cells were stimulated with IL-2 in vitro, killing of both NKLAM Ϫ/Ϫ and ϩ/ϩ NK cells was increased. However, the cytotoxic activity mediated by NKLAM-deficient NK cells never reached the levels of WT NK cells. This indicates that IL-2 enhances the killing activity of NKLAM-deficient NK cells. It also suggests that there is an NKLAM-dependent and NKLAM-independent pathway used by NK cells. This is further supported by the finding that poly(I:C) treatment in vivo enhances NK activity in both NKLAM-deficient and WT mice to the same extent. Because the analysis of perforin-deficient mice led to the delineation of a perforin-independent, Fas-dependent mechanism of cytotoxicity, studies of NKLAM-deficient mice may similarly unveil alternative killing pathways (35) .
NKLAM is found in the membrane of cytolytic granules, suggesting that it might play a role in the migration and/or fusion of granules to the cell membrane during the process of granule exocytosis when NK cells are activated to kill. However, our results indicate comparable release of the soluble granule protein ␤-glucuronidase by both NKLAM Ϫ/Ϫ and WT spleen cells and purified NK cells after PMA and calcium ionophore treatment. Experiments are planned to evaluate the potential role of NKLAM in induction of granule exocytosis by other stimuli.
We also found no differences in expression of the granule proteins perforin, granzyme B, or CD107a (LAMP-1) by flow cytometry and/or immunoblot analysis between NKLAM Ϫ/Ϫ and WT NK cells, indicating that NKLAM does not alter the expression of these proteins. Overall, these results suggest that NKLAM is not involved in granule protein expression and the process of granule exocytosis. However, we cannot rule out the possibility that NKLAM deficiency may lead to an alteration in other granule protein expression and/or function.
In addition to decreased cytotoxic activity against YAC-1 tumor cells mediated by NK cells from NKLAM-deficient mice, these cells also secrete less IFN-␥ than WT NK cells after target cell stimulation. It has been suggested that IFN-␥ is released both synaptically and multidirectionally by NK cells (36) . Studies are in progress to determine whether NKLAM is involved in IFN-␥ production and/or release by either of these two mechanisms.
We used the B16 melanoma model to evaluate the potential role of NKLAM in tumor metastasis in vivo. B16 melanoma cells express low amounts of MHC class I and are readily killed by NK cells. It has been well established that inhibition of NK activity by various methods in vivo is associated with increased B16 pulmonary metastasis. More recently, Kim et al. (37) demonstrated that NK cell-deficient transgenic mice have more than a 60-fold greater number of B16 lung metastases compared with WT mice, confirming a predominant role of NK cells in B16 lung metastasis following i.v. injection. A gender difference in response to B16 melanoma was reported in mice deficient in the NK receptor 2B4 (34) . We found that NKLAM-deficient mice have significantly greater numbers of B16 lung nodules than WT mice (between 3-and 4-fold greater).We observed no gender differences; both male and female NKLAM Ϫ/Ϫ mice showed greater numbers of tumors than their WT gender-matched controls. In addition to having more metastases, both male and female NKLAM-deficient mice had larger tumor nodules than WT mice. These results indicate that NKLAM-deficient mice have diminished capacity to control tumor metastases in vivo and support the role for NKLAM in NK function in vivo. Again, these results suggest a partial rather than absolute defect in NK activity in NKLAM-deficient NK cells.
These studies point to an important role for NKLAM in NK cell function in vivo and in vitro. These NKLAM-deficient mice are a tool for characterizing the function of NKLAM and its role in various disease processes. It also opens up new investigations into alternate, NKLAM-independent mechanisms used by NK cells to control tumors and viruses in vitro and in vivo.
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